Company / Total Debt
Bioventus Inc. Total Debt History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$279.0M
FY2025
5-year range
$279.0M / $385.0M
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Debt has declined for 3 consecutive years, from $385M in FY2022 to $279M in FY2025.
Based on SEC 10-K filings.
$279M in FY2025 with a 3-year CAGR of -10.2%.
Improved from $367M to $279M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -10.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s total debt has declined for 3 consecutive years.
- 3-year CAGR of -10.2%, indicating a declining trend.
- In FY2025, total debt decreased 9.5% year-over-year.
- Peak total debt was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $279.0M | -9.5% |
| FY2024 | $308.3M | -16.0% |
| FY2023 | $367.0M | -4.7% |
| FY2022 | $385.0M | +13.4% |
| FY2021 | $339.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026